GSX 2025
Join Everbridge as we're exhibiting at GSX 2025 in New Orleans this upcoming September.
Keep up to date on recent Everbridge news, events, and content, including from our recent thought leadership events and articles.
Below are reports* † in which we’ve received recognition. In addition to those published here, we are also excited to be included in:
Join Everbridge as we're exhibiting at GSX 2025 in New Orleans this upcoming September.
Business disruptions are no longer rare occurrences. They are a continuous operating challenge forcing organizations to stay ahead of threats to ensure continuity.
Learn how the Everbridge broader resilience strategy is complimented by xMatters as an IT incident response engine to drive business continuity through cutting-edge automation.
From sudden geopolitical events to natural disasters, the disruptions that threaten employee safety are increasing exponentially. This webinar will help show you how to keep your p
Purpose-built AI is transforming critical event management and strategies for organizational resilience. Explore the advanced capabilities of High Velocity CEM with intelligence.
Join us for an in-depth session on how BC in the Cloud is evolving to meet the dynamic needs of business resiliency leaders.
*Forrester reports are available to Forrester subscribers or for purchase.
†Gartner reports are available for Gartner subscribers only
†GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and HYPE CYCLE is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.
†Gartner® does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.